Status:
RECRUITING
Serological and PCR Testing for COVID-19
Lead Sponsor:
Richmond Research Institute
Collaborating Sponsors:
Richmond Pharmacology Limited
Conditions:
COVID-19
Eligibility:
All Genders
5-70 years
Brief Summary
Richmond Research Institute (RRI) is applying existing and new COVID-19 PCR and antibody tests to help develop methodologies which provide fast and accurate results. Infection with coronavirus (SARS-C...
Detailed Description
This is a screening study to measure symptomatic and asymptomatic carriage of SARS-CoV-2 in trial participants to help facilitate early detection of a second wave of SARS-CoV-2 infections. Specificall...
Eligibility Criteria
Inclusion
- Male or female aged 5 to 70 years.
- An understanding, ability, and willingness to fully comply with the project procedures and restrictions.
Exclusion
- Not applicable.
Key Trial Info
Start Date :
March 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04404062
Start Date
March 16 2020
End Date
January 1 2026
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
London, London, United Kingdom, SE1 1YR